Clinicians need to familiarize themselves with menopause genitourinary symptom management so they can address the pressing medical needs of millions of women.

Genitourinary cancers require individualized treatment plans based on type, stage, and patient health, utilizing imaging, ...

Prostate cancer is the second-leading cause of death in American men. However, prostate cancer is curable, thanks to options ...

MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, announced today that its PROSTOX ultra test is now available for ordering in the United States. The ...

From fatigue to neuropathy, managing treatment-related side effects is central to improving quality of life in breast cancer.

Breast cancer survivors with severe menopausal symptoms should be supported to make an informed decision about whether to ...

This Collection provides a comprehensive overview of the crucial role of biomarkers in personalizing genitourinary cancer care. We have brought together informative Review and Perspective articles ...

I am alive but not living,” said one breast cancer survivor, recently. “Cancer took my body, but menopause took my spirit.” ...

HEART disease is the world’s biggest killer. It includes conditions that narrow or block blood vessels and can cause heart ...

A Franco-Swiss study identified consultation time, visit frequency, and diagnosis as key factors in patient-perceived physician empathy.

The phase 3 NRG Oncology GU005 trial tested SBRT vs MH-IMRT radiation for intermediate-risk prostate cancer for disease control and quality of life.

A shorter radiation course improved quality of life among men with intermediate-risk, localized prostate cancer, according to ...